Hickey Benjamin

President, RayzeBio Org. at BMY; EVP, Chief Commercial Officer at Mirati Therapeutics, Inc.

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
11
Latest May 9, 2025
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Jan 18 2022

    Sold 627 shares at $120.48 ($76k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    Sold 1.8% of holdings ($4.3M position)34,976 shares left0.3x usual sizeFiling

  2. 2 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Dec 21 +337 days

    Sold 3,248 shares at $40.41 ($131k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    Sold 6% of holdings ($2.2M position)50,877 shares left1.6x usual sizeFiling

  3. 3 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Jan 9 +19 days

    Sold 2,088 shares at $45.37 ($95k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    Sold 4.1% of holdings ($2.3M position)48,789 shares left1x usual sizeFiling

  4. 4 Form 4 sale Mirati Therapeutics, Inc.Plan not stated
    Jan 17 +8 days

    Sold 1,566 shares at $42.38 ($66k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    Sold 3.2% of holdings ($2.1M position)47,223 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale Mirati Therapeutics, Inc.No plan
    Dec 13 +330 days

    Sold 2,220 shares at $56.67 ($126k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    No 10b5-1 planSold 2.1% of holdings ($6M position)103,694 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale Mirati Therapeutics, Inc.No plan
    Jan 8 +26 days

    Sold 2,090 shares at $58.92 ($123k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    No 10b5-1 planSold 1.7% of holdings ($7.1M position)118,625 shares left1x usual sizeFiling

  7. 7 Form 4 sale Mirati Therapeutics, Inc.No plan
    Jan 16 +8 days

    Sold 1,597 shares at $59.02 ($94k)

    Hickey Benjamin, EVP, Chief Commercial Officer

    No 10b5-1 planSold 1.3% of holdings ($7M position)117,028 shares left0.8x usual sizeFiling

  8. 8 Form 4 sale BMYUnusual
    May 9 +479 days

    Sold 97 shares at $38.01 ($4k)

    Hickey Benjamin, President, RayzeBio Org.

    No 10b5-1 planSold 100% of holdings ($4k position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Hickey Benjamin
Source
May 9, 2025BMYPresident, RayzeBio Org.Form 4 sale97$4k100.0%UnusualSEC
Jan 16, 2024Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale1,597$94k1.3%No planSEC
Jan 8, 2024Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale2,090$123k1.7%No planSEC
Dec 13, 2023Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale2,220$126k2.1%No planSEC
Jan 17, 2023Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale1,566$66k3.2%Plan not statedSEC
Jan 9, 2023Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale2,088$95k4.1%Plan not statedSEC
Dec 21, 2022Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale3,248$131k6.0%Plan not statedSEC
Jan 18, 2022Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale627$76k1.8%Plan not statedSEC
Jan 7, 2022Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale1,964$267k7.3%Plan not statedSEC
Mar 19, 2021Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale2,369$418k8.1%Plan not statedSEC
Jan 7, 2021Mirati Therapeutics, Inc.EVP, Chief Commercial OfficerForm 4 sale2,078$450k9.5%Plan not statedSEC